We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Biomedix, Cites Design Controls, CAPAs
FDA Warns Biomedix, Cites Design Controls, CAPAs
August 1, 2013
Biomedix has received an FDA warning letter citing several design control failures with its manufacture of IV administration sets.